CJC-IPA 5/5mg | Research Peptide | Certified-PEP

Sign up now and get 20% off your order, HAPPY NEW YEAR. See sign up below.

Sign up now and get 20% off your order, HAPPY NEW YEAR. See sign up below.

CJC / IPA 10/10 MG

$110.00

1x CJC / IPA 10/10 MG (20 MG Bottle)

Availability: 816 in stock

- +
Quantity Price
1 - 3 $110.00
4 - 7 $100.00
8+ $90.00
SKU CP_CJC_NO_DAC_IPAMORELIN_10_10MG_3ML_VIAL Category Tags , , , , ,

The Hulk (CJC-1295 No DAC + Ipamorelin) 20 mg is a dual-peptide research formulation combining CJC-1295 (No DAC) and Ipamorelin into a single lyophilized vial. This consolidated presentation contains 10 mg of CJC-1295 No DAC and 10 mg of Ipamorelin, providing a total peptide content of 20 mg while replacing prior multi-vial formats.

CJC-1295 No DAC is a synthetic growth-hormone–releasing hormone (GHRH) analog commonly investigated in preclinical research for its interaction with pituitary GHRH receptors and its role in stimulating pulsatile growth-hormone signaling. Unlike DAC-modified variants, the No-DAC form is characterized by a shorter active window, making it a subject of interest in studies examining endogenous growth-hormone pulse dynamics and regulatory feedback mechanisms.

Ipamorelin is a selective ghrelin-receptor (GHS-R) agonist studied for its ability to stimulate growth-hormone release through a pathway distinct from GHRH analogs, with minimal interaction with other pituitary hormones in experimental models. Research attention has focused on its receptor selectivity, signaling kinetics, and compatibility with GHRH-based compounds.

When paired in a single formulation, CJC-1295 No DAC and Ipamorelin represent complementary growth-hormone–signaling mechanisms—one acting through the GHRH receptor pathway and the other through ghrelin-receptor activation. This combination is frequently examined in research settings to evaluate coordinated or synergistic effects on growth-hormone pulse amplitude, frequency, and downstream signaling cascades.

Current areas of research interest for the CJC-1295 No DAC + Ipamorelin combination include:

  • Growth-hormone secretion dynamics, including pulse frequency and amplitude modulation
  • Pituitary signaling and receptor-pathway interaction studies
  • Metabolic and body-composition research models evaluating GH-mediated signaling effects
  • Recovery and adaptation studies examining endocrine responses to physiological stress
  • Sleep-cycle and circadian-rhythm research related to endogenous GH release patterns

This single-vial Hulk formulation is manufactured to 99% purity as verified by HPLC analysis and is intended strictly for laboratory and research use.
Not for human or veterinary use.

Scroll to Top

Research Use Disclaimer

The products on this website are for legitimate research use only. They are not intended to prevent, treat, or cure any illness or disease and are not intended for human consumption. By accessing this site, you acknowledge that you are at least 18 years of age, understand these terms, and have a legitmate research basis for buying these products.